Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder.

Coccaro EF, Lee RJ, Kavoussi RJ.

J Clin Psychiatry. 2009 Apr 21;70(5):653-62. doi: 10.4088/JCP.08m04150.

PMID:
19389333
2.

[Intermittent explosive disorder: current status].

Amara G, Richa S, Baylé FJ.

Encephale. 2007 May-Jun;33(3 Pt 1):339-45. Review. French.

PMID:
17675932
3.

Intermittent explosive disorder.

Coccaro EF.

Curr Psychiatry Rep. 2000 Feb;2(1):67-71. Review.

PMID:
11122935
4.

Validity of the new A1 and A2 criteria for DSM-5 intermittent explosive disorder.

Coccaro EF, Lee R, McCloskey MS.

Compr Psychiatry. 2014 Feb;55(2):260-7. doi: 10.1016/j.comppsych.2013.09.007. Epub 2013 Oct 19. Review.

PMID:
24321204
5.

Pharmacotherapy of impulsive aggression: a quality comparison of controlled studies.

Felthous AR, Lake SL, Rundle BK, Stanford MS.

Int J Law Psychiatry. 2013 May-Aug;36(3-4):258-63. doi: 10.1016/j.ijlp.2013.04.017. Epub 2013 Apr 30. Review.

PMID:
23642319
6.

Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5.

Coccaro EF.

Am J Psychiatry. 2012 Jun;169(6):577-88. doi: 10.1176/appi.ajp.2012.11081259. Review.

PMID:
22535310
7.

The influence of fluoxetine on aggressive behavior.

Fuller RW.

Neuropsychopharmacology. 1996 Feb;14(2):77-81. Review.

PMID:
8822529
8.

[Intermittent Explosive Disorder: A Controversial Diagnosis].

Zapata JP, Palacio JD.

Rev Colomb Psiquiatr. 2016 Jul-Sep;45(3):214-23. doi: 10.1016/j.rcp.2015.11.001. Epub 2015 Dec 17. Review. Spanish.

PMID:
27569016
9.

[Compulsive buying].

Müller A.

Fortschr Neurol Psychiatr. 2012 Jun;80(6):348-54; quiz 355. doi: 10.1055/s-0032-1312728. Epub 2012 May 29. Review. German. No abstract available.

PMID:
22644521
10.

The neurobiology of aggression and violence.

Rosell DR, Siever LJ.

CNS Spectr. 2015 Jun;20(3):254-79. doi: 10.1017/S109285291500019X. Epub 2015 May 4. Review.

PMID:
25936249

Supplemental Content

Support Center